| Tumor evasion of the immune system by converting CD4+ CD25− T cells into CD4+ CD25+ T regulatory cells: role of tumor-derived TGF-β VC Liu, LY Wong, T Jang, AH Shah, I Park, X Yang, Q Zhang, S Lonning, ... The Journal of Immunology 178 (5), 2883-2892, 2007 | 598 | 2007 |
| An antioxidant response phenotype shared between hereditary and sporadic type 2 papillary renal cell carcinoma A Ooi, JC Wong, D Petillo, D Roossien, V Perrier-Trudova, D Whitten, ... Cancer cell 20 (4), 511-523, 2011 | 403 | 2011 |
| Small cell carcinoma of the urinary bladder: a clinicopathologic analysis of 64 patients L Cheng, CX Pan, XJ Yang, A Lopez‐Beltran, GT MacLennan, H Lin, ... Cancer 101 (5), 957-962, 2004 | 372 | 2004 |
| The deficiency of Akt1 is sufficient to suppress tumor development in Pten+/− mice ML Chen, PZ Xu, X Peng, WS Chen, G Guzman, X Yang, A Di Cristofano, ... Genes & development 20 (12), 1569-1574, 2006 | 311 | 2006 |
| Neuroendocrine differentiation of prostate cancer: a review V Parimi, R Goyal, K Poropatich, XJ Yang American journal of clinical and experimental urology 2 (4), 273, 2014 | 283 | 2014 |
| Prostate-specific membrane antigen expression in the neovasculature of gastric and colorectal cancers MC Haffner, IE Kronberger, JS Ross, CE Sheehan, M Zitt, G Mühlmann, ... Human pathology 40 (12), 1754-1761, 2009 | 276 | 2009 |
| P504S/α-methylacyl-CoA racemase: a useful marker for diagnosis of small foci of prostatic carcinoma on needle biopsy Z Jiang, CL Wu, BA Woda, K Dresser, J Xu, GR Fanger, XJ Yang The American journal of surgical pathology 26 (9), 1169-1174, 2002 | 260 | 2002 |
| A molecular classification of papillary renal cell carcinoma XJ Yang, MH Tan, HL Kim, JA Ditlev, MW Betten, CE Png, EJ Kort, ... Cancer research 65 (13), 5628-5637, 2005 | 253 | 2005 |
| Loss of parafibromin immunoreactivity is a distinguishing feature of parathyroid carcinoma MH Tan, C Morrison, P Wang, X Yang, CJ Haven, C Zhang, P Zhao, ... Clinical Cancer Research 10 (19), 6629-6637, 2004 | 251 | 2004 |
| Molecular subclassification of kidney tumors and the discovery of new diagnostic markers M Takahashi, XJ Yang, J Sugimura, J Backdahl, M Tretiakova, CN Qian, ... Oncogene 22 (43), 6810-6818, 2003 | 237 | 2003 |
| Expression of α-methylacyl-CoA racemase (P504S) in atypical adenomatous hyperplasia of the prostate XJ Yang, CL Wu, BA Woda, K Dresser, M Tretiakova, GR Fanger, Z Jiang The American journal of surgical pathology 26 (7), 921-925, 2002 | 231 | 2002 |
| Small cell carcinoma of the prostate: an immunohistochemical study JL Yao, R Madeb, P Bourne, J Lei, X Yang, S Tickoo, Z Liu, D Tan, ... The American journal of surgical pathology 30 (6), 705-712, 2006 | 223 | 2006 |
| Expression of alpha-methylacyl-CoA racemase in papillary renal cell carcinoma MS Tretiakova, S Sahoo, M Takahashi, M Turkyilmaz, NJ Vogelzang, ... The American journal of surgical pathology 28 (1), 69-76, 2004 | 221 | 2004 |
| Molecular genetic evidence for a common clonal origin of urinary bladder small cell carcinoma and coexisting urothelial carcinoma L Cheng, TD Jones, RP McCarthy, JN Eble, M Wang, GT MacLennan, ... The American journal of pathology 166 (5), 1533-1539, 2005 | 216 | 2005 |
| Tubulocystic carcinoma of the kidney: clinicopathologic and molecular characterization XJ Yang, M Zhou, O Hes, S Shen, R Li, J Lopez, RB Shah, Y Yang, ... The American journal of surgical pathology 32 (2), 177-187, 2008 | 196 | 2008 |
| Alpha‐methylacyl‐CoA racemase: a multi‐institutional study of a new prostate cancer marker Z Jiang, CL Wu, BA Woda, KA Iczkowski, PG Chu, MS Tretiakova, ... Histopathology 45 (3), 218-225, 2004 | 196 | 2004 |
| Glypican 3: a novel marker in testicular germ cell tumors DL Zynger, ND Dimov, C Luan, BT Teh, XJ Yang The American journal of surgical pathology 30 (12), 1570-1575, 2006 | 190 | 2006 |
| Benign metastasizing leiomyoma: clonality, telomere length and clinicopathologic analysis KT Patton, L Cheng, V Papavero, MG Blum, AV Yeldandi, BP Adley, ... Modern pathology 19 (1), 130-140, 2006 | 187 | 2006 |
| Glypican-3 as a useful diagnostic marker that distinguishes hepatocellular carcinoma from benign hepatocellular mass lesions HL Wang, F Anatelli, QJ Zhai, B Adley, ST Chuang, XJ Yang Archives of pathology & laboratory medicine 132 (11), 1723-1728, 2008 | 180 | 2008 |
| Immunohistochemical distinction between primary adenocarcinoma of the bladder and secondary colorectal adenocarcinoma HL Wang, DW Lu, LM Yerian, N Alsikafi, G Steinberg, J Hart, XJ Yang The American journal of surgical pathology 25 (11), 1380-1387, 2001 | 178 | 2001 |
Maria TretiakovaProfessor, Anatomic and Clinical pathologist, University of WashingtonVerified email at uw.edu
